コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 be a biocompatible all-aqueous platform for cell encapsulation.
2 rving their favorable characteristics for 3D cell encapsulation.
3 centration, providing a useful timeframe for cell encapsulation.
4 lications ranging from controlled release to cell encapsulation.
6 adequate oxygenation is a major challenge in cell encapsulation, a therapy which holds potential to t
7 Thus, in vivo transcriptomic profiling using cell encapsulation allows for the characterization of ef
10 emplated emulsification, which allows single-cell encapsulation and barcoding of cDNA in uniform drop
16 rial or specific cell types at the moment of cell encapsulation and the absence of implementable mult
20 PNA microcapsule and the one-step method of cell encapsulation can be a versatile 3D NIM system for
22 yed which produced large droplets capable of cell encapsulation (diameter, ~25microm) and small empty
23 pin many applications in tissue engineering, cell encapsulation, drug delivery and bioelectronics.
25 ding controlled bioactive molecule delivery, cell encapsulation for controlled three-dimensional cult
28 vo, we developed a technique based on single-cell encapsulation in droplets of a monodisperse microfl
30 ust, easy-to-use workflow for precise single-cell encapsulation into picoliter-scale double emulsion
31 roplet generation with a single particle and cell encapsulation is a random process and suffers from
33 s), alongside advances in stem cell biology, cell encapsulation methodologies, and immunotherapy, wil
34 applications such as in tissue engineering, cell encapsulation, microfluidics, bioengineering and dr
38 Our research adds to current knowledge in cell-encapsulation strategies by highlighting the import
40 eveloped a clinically validated, implantable cell encapsulation system that delivers high and consist
41 omposition will be required to enable viable cell encapsulation, the functionalized injectable hydrog
42 ginates may contribute to the development of cell encapsulation therapies for type 1 diabetes and oth
44 particles in several applications including cell encapsulation, three-dimensional cell culture, and
45 us biomedical applications, including living cell encapsulation, tissue engineering, and stimuli resp
46 r therapies for type-1 diabetes can leverage cell encapsulation to dispense with immunosuppression.
47 es (EVs), we developed a porous material for cell encapsulation which would improve donor cell retent